Literature DB >> 29920599

T-Cell Responses in Adults During Natural Respiratory Syncytial Virus Infection.

D Roumanes1, A R Falsey2,3, S Quataert1, S Secor-Socha1, F E-H Lee2, H Yang4, S Bandyopadhyay4, J Holden-Wiltse4, D J Topham1, E E Walsh2,3.   

Abstract

Background: The pathogenesis of respiratory syncytial virus (RSV) in older adults may be due to age-related T-cell immunosenescence. Thus, we evaluated CD4 and CD8 T-cell responses during RSV infection in adults across the age spectrum.
Methods: Peripheral blood mononuclear cells collected during RSV infection in adults, age 26-96 years, were stimulated with live RSV and peptide pools representing F, M, NP, and G proteins and analyzed by flow cytometry.
Results: There were no significant age-related differences in frequency of CD4+ T cells synthesizing interferon (IFN)γ, interleukin (IL)2, IL4, IL10, or tumor necrosis factor (TNF)α or in CD8+IFNγ+ T cells. IL4+CD4+ T-cell numbers were low, as were IL13 and IL17 responses. However, in univariate analysis, CD4 T-cell IFNγ, IL2, IL4, IL10, and TNFα responses and CD8+IFNγ+ T cells were significantly increased with more severe illness requiring hospitalization. In multivariate analysis, viral load was also associated with increased T-cell responses. Conclusions: We found no evidence of diminished RSV-specific CD4 or CD8 T-cell responses in adults infected with RSV. However, adults with severe disease seemed to have more robust CD4 and CD8 T-cell responses during infection, suggesting that disease severity may have a greater association with T-cell responses than age.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29920599      PMCID: PMC6049038          DOI: 10.1093/infdis/jiy016

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  47 in total

1.  CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection.

Authors:  T Hussell; C J Baldwin; A O'Garra; P J Openshaw
Journal:  Eur J Immunol       Date:  1997-12       Impact factor: 5.532

2.  Long-term persistence and reactivation of T cell memory in the lung of mice infected with respiratory syncytial virus.

Authors:  T Ostler; T Hussell; C D Surh; P Openshaw; S Ehl
Journal:  Eur J Immunol       Date:  2001-09       Impact factor: 5.532

3.  Viral shedding and immune responses to respiratory syncytial virus infection in older adults.

Authors:  Edward E Walsh; Derick R Peterson; Aja E Kalkanoglu; Frances Eun-Hyung Lee; Ann R Falsey
Journal:  J Infect Dis       Date:  2013-02-04       Impact factor: 5.226

4.  The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice.

Authors:  John S Tregoning; Yuko Yamaguchi; James Harker; Belinda Wang; Peter J M Openshaw
Journal:  J Virol       Date:  2008-02-13       Impact factor: 5.103

5.  Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

Authors:  B S Graham; L A Bunton; P F Wright; D T Karzon
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

6.  Respiratory syncytial viral infection in children with compromised immune function.

Authors:  C B Hall; K R Powell; N E MacDonald; C L Gala; M E Menegus; S C Suffin; H J Cohen
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

Review 7.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

Authors:  Claudio Franceschi; Judith Campisi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-06       Impact factor: 6.053

8.  Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects.

Authors:  Maria Grazia Cusi; Barbara Martorelli; Giuseppa Di Genova; Chiara Terrosi; Giuseppe Campoccia; Pierpaolo Correale
Journal:  Immun Ageing       Date:  2010-10-20       Impact factor: 6.400

9.  The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness.

Authors:  F Eun-Hyung Lee; Edward E Walsh; Ann R Falsey
Journal:  Chest       Date:  2011-05-12       Impact factor: 9.410

10.  Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adults.

Authors:  Kyle Widmer; Marie R Griffin; Yuwei Zhu; John V Williams; H Keipp Talbot
Journal:  Influenza Other Respir Viruses       Date:  2014-02-07       Impact factor: 4.380

View more
  8 in total

1.  Environmental Cadmium Enhances Lung Injury by Respiratory Syncytial Virus Infection.

Authors:  Xin Hu; Ki-Hye Kim; Youri Lee; Jolyn Fernandes; M Ryan Smith; Yu-Jin Jung; Michael Orr; Sang-Moo Kang; Dean P Jones; Young-Mi Go
Journal:  Am J Pathol       Date:  2019-05-18       Impact factor: 4.307

2.  Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations.

Authors:  N C Salisch; A Izquierdo Gil; D N Czapska-Casey; L Vorthoren; J Serroyen; J Tolboom; E Saeland; H Schuitemaker; R C Zahn
Journal:  NPJ Vaccines       Date:  2019-12-20       Impact factor: 7.344

3.  Aims, Study Design, and Enrollment Results From the Assessing Predictors of Infant Respiratory Syncytial Virus Effects and Severity Study.

Authors:  Edward E Walsh; Thomas J Mariani; ChinYi Chu; Alex Grier; Steven R Gill; Xing Qiu; Lu Wang; Jeanne Holden-Wiltse; Anthony Corbett; Juilee Thakar; Matthew N McCall; David J Topham; Ann R Falsey; Mary T Caserta; Lauren Benoodt
Journal:  JMIR Res Protoc       Date:  2019-06-06

Review 4.  Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development.

Authors:  Seyhan Boyoglu-Barnum; Tatiana Chirkova; Larry J Anderson
Journal:  Front Immunol       Date:  2019-07-25       Impact factor: 7.561

5.  ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calves.

Authors:  Rineke de Jong; Norbert Stockhofe-Zurwieden; Judith Bonsing; Kai-Fen Wang; Sarah Vandepaer; Badiaa Bouzya; Jean-François Toussaint; Ilse Dieussaert; Haifeng Song; Ann-Muriel Steff
Journal:  Nat Commun       Date:  2022-10-17       Impact factor: 17.694

Review 6.  Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population.

Authors:  Laura M Stephens; Steven M Varga
Journal:  Vaccines (Basel)       Date:  2021-06-09

Review 7.  Immunosenescence and human vaccine immune responses.

Authors:  Stephen N Crooke; Inna G Ovsyannikova; Gregory A Poland; Richard B Kennedy
Journal:  Immun Ageing       Date:  2019-09-13       Impact factor: 9.701

8.  Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations.

Authors:  N C Salisch; A Izquierdo Gil; D N Czapska-Casey; L Vorthoren; J Serroyen; J Tolboom; E Saeland; H Schuitemaker; R C Zahn
Journal:  NPJ Vaccines       Date:  2019-12-20       Impact factor: 7.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.